Poster
Mepolizumab Improves Health-Related Quality of Life for Patients With Chronic Rhinosinusitis With Nasal Polyps: Data From the SYNAPSE Study
Author
Lee SE
Condition
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Drug target
IL-5
Drug moa
anti–IL-5 humanized monoclonal antibody
Source url
s3://convoke-optic-posters/2024-05-10/5_Lee_205687_AAAAI-2021_poster.pdf
10 organizations
1 product
Product
MepolizumabOrganization
Patient-Centred Outcomes, Adelphi ValuesOrganization
Eastern Virginia Medical SchoolOrganization
John Hopkins School of MedicineOrganization
Global Medical Affairs, GSKOrganization
Clinical Statistics, GSKOrganization
Respiratory Therapeutic Area, GSK